🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This double-blind 8 week study will evaluate dose response, efficacy (blood...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-06
Trial ID
NCT01150357
Treatments Being Tested
The blood brain barrier (BBB) prevents some drugs from successfully reachin...
Status
Recruiting
Location
Columbia University Irving Medical Center
Start Date
2023-06-05
Trial ID
NCT05762419
Treatments Being Tested
This trial in healthy subjects will assess PUR118's effect on attenuating o...
Status
Completed
Location
Fraunhofer Institut fur Toxicologie und Experimentelle Medicine (ITEM)
Start Date
2012-08
Trial ID
NCT01690949
Treatments Being Tested
Persons diagnosed with thyroid cancer are often treated initially with a th...
Status
Recruiting
Location
University of California, San Francisco
Start Date
2025-12-04
Trial ID
NCT06961084
Treatments Being Tested
Despite advances in medications, allergic diseases, including allergic asth...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2013-01
Trial ID
NCT01711593
Treatments Being Tested
The purpose of the study is to determine the safety, tolerability, and phar...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-01
Trial ID
NCT06570434
Treatments Being Tested
Laparoscopic cholecystectomy is a frequently performed surgical procedure a...
Status
Recruiting
Location
Ankara Etlik City Hospital
Start Date
2025-06-02
Trial ID
NCT06932835
Treatments Being Tested
This is a safety and efficacy study evaluating a experimental treatment for...
Status
Completed
Location
Site Reference ID/Investigator# 75139
Start Date
2012-05
Trial ID
NCT01655680
SPH3127 tablet is a of renin inhibitor. It is expected to be a new drug for...
Status
Completed
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2019-01-11
Trial ID
NCT03756103
Treatments Being Tested
This Phase 2 trial will evaluate the safety and efficacy of ABP-450 for the...
Status
Completed
Location
Arizona Neuroscience Research
Start Date
2021-03-29
Trial ID
NCT04849988